Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Ozagrel hydrochloride effectively prevents development of preeclampsia in pregnant women

Nov. 19, 1998

Safe and effective treatment of acute CHF with nesiritide

Nov. 19, 1998

Endothelin antagonists a focus of R&D at Merck KGaA

Nov. 19, 1998

New compound described for the treatment of pregnancy-induced hypertension

Nov. 19, 1998

5-HT antagonists in development at Synthelabo for cardiovascular and other disorders

Nov. 18, 1998

Synthesis and use of novel ET-antagonist series disclosed by Merck KGaA

Nov. 18, 1998

Cytel receives FDA grant to further development of selectin inhibitor

Nov. 18, 1998

Collateral Therapeutics draws nearer to an effective gene therapy for CHF

Nov. 17, 1998

Na+/Ca2+ exchange inhibitors patented by Taisho

Nov. 16, 1998

More news from AHA: azimilide prevents atrial fibrillation

Nov. 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...